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Review
Bacterial phospholipase A: structure and function of an integral
membrane phospholipase
H.J. Snijder, B.W. Dijkstra *
Laboratory of Biophysical Chemistry, BIOSON Research Institute, University of Groningen,
Nijenborgh 4, 9747 AG Groningen, The Netherlands
Abstract
Within the large family of lipolytic enzymes, phospholipases constitute a very diverse subgroup with physiological
functions such as digestion and signal transduction. Most phospholipases may associate with membranes at the lipid-water
interface. However, in many Gram-negative bacteria, a phospholipase is present which is located integrally in the bacterial
outer membrane. This phospholipase (outer membrane phospholipase A or OMPLA) is involved in transport across the
bacterial outer membrane and has been implicated in bacterial virulence. OMPLA is calcium dependent and its activity is
strictly regulated by reversible dimerisation. Recently the crystal structure of this integral membrane enzyme has been
elucidated. In this review, we summarise the implications of these structural data for the understanding of the function and
regulation of OMPLA, and discuss a mechanism for phospholipase dependent colicin release in Escherichia coli. ß 2000
Elsevier Science B.V. All rights reserved.
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1. Introduction
1.1. Phospholipases
Lipolytic enzymes form a large family of enzymes
which catalyse the hydrolysis of lipids and phospho-
lipids. Phospholipases constitute a very diverse sub-
group of enzymes belonging to this family, compris-
ing enzymes with phosphodiesterase as well as acyl
hydrolase activity. Of the acyl hydrolases, the 14
kDa disulphide bond rich pancreatic and snake ven-
om phospholipases have been studied in most detail
during the past 40 years. More recently, it was found
that this group of enzymes, however, is much larger
and has a much broader cellular distribution than
originally expected [1]. Moreover, other soluble
phospholipases, not homologous to the disulphide
bond rich phospholipases, have been discovered.
Amongst them, the mammalian 85 kDa cytosolic
phospholipase [2] has been implicated in in£amma-
tory responses. Yet another member, which has nei-
ther sequence homology to the disulphide bond rich
phospholipases nor to the cytosolic phospholipases,
is the outer membrane phospholipase A from Esche-
richia coli. It is an integral membrane protein located
in the outer membrane of many Gram-negative bac-
teria. Here we review the current biochemical and
structural knowledge of this enzyme, outer mem-
brane phospholipase A (OMPLA).
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1.2. History and enzyme characteristics
In 1971 Doi et al. [3] reported a membrane-asso-
ciated phospholipase A and lysophospholipase activ-
ity in E. coli. In the same year Scandella and Korn-
berg [4] isolated and puri¢ed a membrane bound
phospholipase A1 from E. coli. Some years later,
these di¡erent activities were attributed to one en-
zyme located integrally in the outer membrane
[5,6]. This 31 kDa enzyme, outer membrane phos-
pholipase A (or detergent-resistant phospholipase,
pldA protein) appeared to contain 269 amino acids
residues preceded by a 20 amino acid signal sequence
which targets the protein across the inner membrane
[7]. The enzyme is strictly calcium dependent [6] and
displays a broad substrate speci¢city. Besides phos-
pholipase A1 and A2 activity the enzyme also har-
bours lysophospholipase A1 and A2 activity, and
mono- and diacylglyceride lipase activity. The mini-
mal substrate requirements of the enzyme are a more
or less polar head group esteri¢ed to an acyl chain of
at least 14 carbon atoms [8].
1.3. Activation
OMPLA activity and phospholipid turnover are
triggered by such diverse events as phage-induced
lysis [9], temperature shift [10], spheroplast formation
[11], EDTA treatment [12], polymixin B exposure
[13], heat shock [14] and colicin release [15^17]. Fur-
thermore, increased levels of phospholipase A activ-
ity have been observed in E. coli variants which dis-
play decreased stability of the cell envelope (B fad
cells [18] and envC mutations [19]). All these diverse
conditions and triggers have in common that the out-
er membrane integrity is perturbed, indicating that
the activity of OMPLA is correlated with loss of
envelope integrity.
1.4. Physiological function
The pldA gene is widespread among Gram-nega-
tive bacteria (Fig. 1), indicative of an important
function of the gene product. The role of OMPLA
has been most thoroughly studied in E. coli, where it
participates in the secretion of bacteriocins. Bacter-
iocin release is triggered by a lysis protein (bacterio-
cin release protein or BRP), followed by a phospho-
lipase dependent accumulation of lysophospholipids
and free fatty acids in the outer membrane. The re-
action products enhance the permeability of the out-
er membrane, which allows the semispeci¢c secretion
of bacteriocins. [15,17,20,21]. In pldA3 strains, bac-
teriocin secretion is perturbed and the bacteriocins
are accumulated in the cytoplasm [17].
In pathogenic bacteria, phospholipases have been
implicated as virulence factors. Grant et al. [22] dem-
onstrated that the pldA product is a major haemo-
lytic factor in Campylobacter coli [22]. Bukholm et al.
[23] identi¢ed a Helicobacter pylori variant with a
high lysophospholipid content in its outer mem-
brane. This variant showed an increased invasive ca-
pacity, and an increased VacA and urease release.
From these results it has been suggested that release
of VacA and urease could be mechanistically similar
to bacteriocin release in E. coli and that phospholi-
pase A activation is responsible for the increased
lysophospholipid levels [23].
The constitutive expression of OMPLA, even in E.
coli strains that do not possess bacteriocin encoding
plasmids, suggests that there must be additional
physiological roles for the phospholipase. One spec-
ulative function of OMPLA is related to organic sol-
vent tolerance in bacteria. Pedrotta and Witholt [24]
postulated that outer membrane perturbations
caused by organic solvents would activate OMPLA,
resulting in an increased hydrolysis of outer mem-
brane phospholipids and increased release of fatty
acids. The fatty acids are a substrate for the periplas-
mic cis-trans isomerase (CTI), an enzyme that iso-
merises cis fatty acids to the trans conformation.
Phospholipids containing trans fatty acids decrease
the membrane £uidity and permeability. Such a de-
crease is part of the solvent tolerance of bacteria.
C
Fig. 1. Sequence alignment of outer membrane phospholipases produced by Clustal W [42] and Alscript [43]. Residue numbering and
secondary structure elements are according to E. coli OMPLA. Residues boxed in grey and black are highly and strictly conserved res-
idues, respectively. The catalytic triad is indicated by the black triangles. In the H. pylori sequences a long insertion indicated by a
box is omitted from the alignment.
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The trans fatty acids have to be reincorporated in
phospholipids, by an as yet unknown mechanism.
Whereas the involvement of CTI in solvent tolerance
is demonstrated [25], the role of OMPLA in this pro-
cess still needs to be clari¢ed.
2. Structure
2.1. Fold
Structural studies on OMPLA started with the de-
termination of the nucleotide sequence of the pldA
gene. The rather hydrophilic character and the lack
of long hydrophobic amino acid stretches, indicated
that the interaction of OMPLA with the membrane
di¡ered from integral membrane proteins such as
bacteriorhodopsin [7]. Circular dichroism (CD) mea-
surements indicated a high L-strand content [26] and
this led Brok et al. [27] to propose a molecular model
with a L-barrel architecture. Electron crystallography
con¢rmed the L-barrel character; projection maps
showed an oval ring-like density large enough to ac-
commodate 12 L-strands. An elongated domain pro-
trudes from the L-barrel with a size of about 10U25
Aî [28]. Overexpression and a protocol for refolding
of inclusion bodies [26] paved the way for detailed
structural analysis by X-ray crystallography. Crystals
suitable for X-ray analysis were grown using deter-
gent solubilised protein and an organic solvent as
precipitant [29]. The X-ray structure was published
recently [30].
OMPLA has a 12 stranded antiparallel L-barrel
composed of a convex and a £at side with approx-
imate dimensions of 20U30U45 Aî 3 (Fig. 2A,B) [30].
Amphipathic L-strands traverse the membrane, pre-
senting a cylindrical hydrophobic protein surface. On
either side of the hydrophobic cylinder, regions occur
which are rich in aromatic residues. Neighbouring
L-strands are joined by loops and turns which have
a polar character. The enzyme’s interior is polar and
contains an intricate hydrogen bonding network pro-
viding a rigid structure. Two internal cavities exist
that contain water molecules, which are capped by
hydrophobic residues. Epitope insertion studies [31]
identi¢ed the orientation of OMPLA in the mem-
brane; the loop region is located at the extracellular
side while the termini and turns are oriented towards
the periplasm.
2.2. Active site
First hints for the active site residues were circum-
stantial, when it was found that trans-esteri¢cation
with methanol resulted in fatty acid methyl esters [3],
similar to the lipases from the serine hydrolase fam-
ily. This suggested that a serine might be a catalytic
residue. Later, the ¢nding of an inactive Ser152Phe
variant of OMPLA suggested that residue 152 was
the active site serine [27]. This hypothesis was re-
jected, however, when site directed mutagenesis dem-
onstrated some tolerance at this position (Ser152Asn
and Ser152Thr) [32]. De¢nite evidence for a serine as
catalytic nucleophile came from inhibition studies
with hexadecanesulphonyl £uoride. A stoichiometric
amount of hexadecanesulphonyl £uoride led to an
irreversible loss of enzyme activity and resulted in
sulphonylation of serine 144 [33]. Site directed muta-
genesis of Ser144 supported this ¢nding; only the
Ser144Cys mutant had some residual activity (ap-
prox. 1%). This has been observed more often for
serine-cysteine mutations in the serine hydrolase fam-
ily [32].
The ¢nding of the active site serine led to the belief
that OMPLA could be a member of the class of
serine hydrolases and could have a classical Ser-
His-Asp triad. Inactivation experiments using p-bro-
mophenacyl bromide suggested that one out of the
¢ve histidines was involved in catalysis [7]. Later, this
inhibition proved to be rather non-speci¢c. Never-
theless, site directed mutagenesis unequivocally dem-
onstrated that one histidine, His142, was catalytically
essential, with the His142Gly variant displaying a
four orders of magnitude lower activity than the
wild-type enzyme [34].
The active site residues His142 and Ser144 are lo-
cated at the exterior of the L-barrel, at the outer
lea£et side of the membrane. This location indicates
that under normal conditions the substrate and the
active site are physically separated, since in E. coli
phospholipids are exclusively located in the inner
lea£et of the outer membrane. The constellation of
active site residues resembles that of classical serine
hydrolases, however, with an asparagine residue
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(Asn156) orienting the histidine residue instead of an
aspartate residue in the classical serine hydrolase tri-
ad. Recent site directed mutagenesis studies con-
¢rmed the importance of Asn156 in catalysis. How-
ever, the asparagine residue shows only a modest
contribution to catalysis, as an Asn156Ala mutant
retained 5% residual activity [46]. Moreover, while
Ser144 and His142 are strictly conserved, Asn156
can vary among the di¡erent species; an aspartate
residue is observed in Panthoea agglomerans OM-
PLA [27] and a glutamine residue is observed in H.
pylori OMPLA [35,36]. Furthermore, the Asn156Asp
substitution in E. coli OMPLA yields an active spe-
cies [46]. Glutamine and asparagine carboxamides
are chemically identical and should impose no cata-
lytic di⁄culty except for a change in active site ge-
ometry. Similar variations have been observed in li-
pases as well, where both aspartate and glutamate
may occur in catalytic triads. Thus, OMPLA belongs
to the family of serine hydrolases and demonstrates
the suitability of an asparagine as the third residue in
the catalytic triad.
Fig. 2. Orthogonal views of the crystal structures of the OMPLA monomer (A,B) and dimer (C,D). Active site residues and the hexa-
decanesulphonyl moiety are represented in ball-and-stick, calcium ions are represented by large spheres. The active sites are indicated
by an arrow. Molscript [44] and Raster3D [45] were used to prepare this ¢gure.
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3. Activation and regulation
3.1. Dimerisation
3.1.1. Evidence for dimers
Strict regulation of the phospholipase activity is
necessary since uncontrolled activity can have lethal
consequences for the bacterium [16]. Regulation
must occur at the protein level, since OMPLA is
constitutively expressed and overproduction causes
no phenotypic variations [14,37]. In vitro, the phos-
pholipase activity is modulated in a calcium depen-
dent manner by reversible dimerisation. Inhibition by
hexadecanesulphonyl £uoride stabilises the dimeric
form of OMPLA [38]. In vivo, chemical cross-linking
studies indicate the presence of the monomeric form
of OMPLA in the outer membrane [38]. Soni¢cation
or induction of bacteriocin release protein activates
OMPLA which is a process concurring with dimer-
isation [39].
Fluorescence resonance energy transfer (FRET)
and chemical cross-linking experiments showed that
dimerisation is dependent on the presence of calcium
and substrate [40]. However, these experiments also
supplied evidence for another form of regulation,
modulated by the physical state of the outer mem-
brane lipids. In a bilayer environment, dimeric OM-
PLA displays low activity even in excess of calcium.
Perturbation of these bilayers by detergents results in
a 70-fold increase in activity.
3.1.2. Dimer structure
OMPLA dimers are formed by the association of
two enzyme monomers interacting via the £at barrel
side (Fig. 2C,D) [30]. The association mode observed
in the crystal structure is supported by cross-linking
experiments using H26C single cysteine mutants.
Residue 26 is located close to the £at side of the L-
barrel OMPLA, and cysteine residues at this position
can be e¡ectively cross-linked to produce an active
dimer complex [40]. Dimeric and monomeric OM-
PLA hardly exhibit structural di¡erences, only the
N-terminal loop, which precedes the ¢rst strand,
lacks interpretable density in dimeric OMPLA. Com-
parison of the X-ray crystal structure and electron
microscopy projection maps of monomeric OMPLA
indicate a high £exibility of this loop [28] (Snijder et
al., manuscript in preparation).
3.1.3. Formation of substrate binding pockets
Dimerisation creates two extended clefts along the
subunit interface which run down from the two ac-
tive sites. Both clefts are approx. 25 Aî long with a
sharp bend after 15 Aî , and they are lined with hydro-
phobic and aromatic residues. These clefts bind all 16
carbon atoms of the inhibitor hexadecanesulphonyl
£uoride (Fig. 3). Both monomers interact with the
Fig. 3. Close up of the active site of the dimeric complex cova-
lently inhibited with hexadecanesulphonyl. All residues that are
involved in substrate binding and catalysis are shown in ball-
and-stick, grey and black labels discriminate the two OMPLA
molecules in the dimer. The arrow indicates the sulphonyl oxy-
gen that occupies the oxyanion hole. Molscript [44] and Ras-
ter3D [45] were used to prepare this ¢gure.
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inhibitors and this explains the observed stabilisation
of the dimer upon inhibition. The clefts bind only
one acyl chain from the substrate. The residues
that line these pockets are not strictly conserved,
but most mutations are conservative and maintain
the hydrophobic character of the pockets. Thus,
although a monomer contains a catalytic triad, the
monomeric enzyme form lacks catalytic activity due
to absence of substrate binding pockets, which are
formed only in the dimeric complex [30].
The architecture of the catalytic site and substrate
binding clefts allow a broad range of substrates to
bind. The active sites are exposed to the solvent and
can accommodate a large variety of polar head
groups, varying from as small as a glycol unit to a
complete Tween 20 head group (polyoxyethylene (20)
sorbitan). As a consequence of the one rather non-
speci¢c acyl binding site, substrates with either one
or two acyl chains of various lengths can be produc-
tively bound. Long hydrocarbon chains can extend
in the substrate binding pocket and into the hydro-
phobic membrane core. Short chain length substrates
(912 carbon atoms) are less e¡ectively hydrolysed
[8], which is probably related to their lesser e⁄ciency
to induce dimerisation as only the carbon atoms at
the end of the acyl chain (from C12) have interaction
with the neighbouring molecule.
3.1.4. Protein-protein interactions
The dimer interaction surface is almost exclusively
con¢ned to the hydrophobic membrane embedded
part. Only three main chain hydrogen bonds form
the interactions in the polar loops and turns region
of OMPLA [30]. In the hydrophobic part, the inter-
face contains a patch of four leucines on both mono-
mers which have a knob-and-hole interaction.
Although these are not fully conserved, the hydro-
phobic character of the interaction is maintained.
Additional stabilisation of the dimer complex occurs
via aromatic stacking, conserved in all but the
H. pylori OMPLA. However, the key feature in di-
merisation is a double hydrogen bond formed be-
tween the Gln94 residue side chain of both mono-
mers, a residue which is embedded in the
hydrophobic interior of the dimer. The importance
of this polar protein-protein interaction is exempli-




Calcium is an essential cofactor for activity of
OMPLA [6]. It is rather strongly bound, with a dis-
sociation constant of 10^15 WM. Calcium can be re-
placed by strontium, albeit with a 10-fold higher dis-
sociation constant and a substantially lower activity.
Magnesium and barium cannot replace calcium as
the catalytic cofactor. They are in fact competitive
inhibitors with dissociation constants in the millimo-
lar range [8]. In vitro, calcium is required for dimer-
isation [38]. Kinetic experiments indicate the in£u-
ence of the detergent on the calcium a⁄nity. A 70-
fold lower a⁄nity (millimolar range) is observed in
essays with non-ionic detergents compared to essays
with alkylphosphocholine detergents. Various direct
binding techniques (gel ¢ltration, £uorescence spec-
troscopy and isothermal titration calorimetry) char-
acterised calcium binding in detail [41]. Two binding
sites are present per monomer, one high a⁄nity cal-
cium binding site (KdW36 WM) and a second binding
site with a 10-fold lower a⁄nity (KdW358 WM). As
dimerisation occurs at low Ca2 concentration, this
suggests that the ¢rst calcium ion plays a role in
dimer stabilisation. Sulphonylation of OMPLA (by
hexadecanesulphonyl £uoride) changes the calcium
binding behaviour and two high a⁄nity (KdW48
WM) calcium sites were detected in the inhibited en-
zyme [41].
3.2.2. Structural evidence
One calcium binding site was identi¢ed in the
structure of monomeric OMPLA. The calcium ion
in this site is located approx. 10 Aî away from the
active site and is bound between loops L3 and L4
(L3L4 site). Calcium could be substituted for the
lanthanide ion Sm3. Two aspartate side chain car-
boxylates act as ligands (Asp149 and Asp184). These
residues show some evolutionary variation. Aspar-
tate 149 is replaced by arginine in the Neisseria men-
ingitides and Neisseria gonorrhoeae OMPLA. In H.
pylori and Bordetella pertussis OMPLA this aspartate
is replaced by a glycine, while aspartate 184 is re-
placed by a serine and a glutamic acid residue re-
spectively. Such variation strongly suggests that en-
zymes from the di¡erent sources will show a di¡erent
calcium dependence, most likely changing the dimer-
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isation behaviour as well as the calcium dependence
of activity (Snijder et al., manuscript in preparation).
After dimerisation a second Ca2 binding site is
present. It is located in the active site at the dimer
interface (catalytic calcium site). The calcium ion is
ligated by the side chain of Ser152 and by one main
chain carbonyl oxygen atom from each monomer.
Water molecules complete the ligation sphere result-
ing in a binding site with a bipyramidal octahedral
geometry. The contribution of both monomers to the
binding of calcium correlates with the biochemical
evidence that calcium is needed for dimerisation.
The structures supply only relative information on
the binding a⁄nities of the two di¡erent calcium
binding sites. In the dimeric crystal structure, the
a⁄nity of the catalytic calcium site is higher than
that of the L3L4 binding site, since only the catalytic
calcium ion could be modelled with con¢dence in the
experimental electron density maps. The opposite sit-
uation occurs in the crystal structure of monomeric
OMPLA, where the calcium ion could only be ob-
served in the L3L4 binding site.
Calcium has an essential catalytic role, which is
illustrated by the dimeric hexadecanesulphonyl-in-
hibited structure. This hexadecanesulphonyl inhibitor
mimics the negatively charged tetrahedral intermedi-
ate of the acylation reaction of serine hydrolases. In
classical serine hydrolases, stabilisation of the nega-
tive charge during catalysis is supplied by donation
of two or three hydrogen bonds by a structural fea-
ture, which is called the oxyanion hole. In OMPLA,
the sulphonyl oxygen atom which proposedly would
develop a negative charge during catalysis, forms
hydrogen bonds with the main chain amide from
residue glycine 146 and two water molecules. The
calcium ion positions these water molecules in the
active site and polarises them. Thus, the calcium
ion stabilises negatively charged intermediates during
catalysis via water molecules.
In the OMPLA Michaelis-Menten complex, the
substrate would be oriented with the carbonyl oxy-
gen atom of the ester towards the calcium ion. This
orientation causes the carbonyl bond to become po-
larised and increases the electrophilicity of the car-
bonyl carbon atom, which will facilitate the nucleo-
philic attack by serine 144. Thus, the contribution of
calcium to catalysis stems (i) from the polarisation of
the substrate ester carbonyl group and (ii) from sta-
bilisation of negatively charged reaction intermedi-
ate. These roles of the calcium ion suggest that the
catalytic importance of the strictly conserved Ser152
is related to its calcium ligating capacity and its con-
tribution to correctly positioning of the calcium ion
[30].
3.2.3. Binding model
The various parameters that in£uence calcium
binding and that modulate the a⁄nity of OMPLA
for calcium, hamper a full understanding of the com-
plex calcium binding process. Nevertheless, a work-
ing model for calcium binding emerges from the
combined structural and biochemical data. In the
natural environment of OMPLA, calcium is bound
to monomeric phospholipase with high a⁄nity. Only
after dimerisation, the catalytic calcium site is
formed. Active site occupation and dimerisation re-
sults in an increased calcium a⁄nity of the active site
calcium binding site. Subsequent transfer of calcium
to the catalytic site results in the active complex. A
second calcium can be now bound to the empty
binding site between loops L3 and L4 yielding a
dimer complex with two calcium ions per monomer.
Although the role of calcium in catalysis seems clear,
this is much less so for its role in the regulation of
the activity of OMPLA. As calcium ions are abun-
dant in the bacterial outer membrane environment, it
is questionable whether the in vitro observed calcium
dependent dimerisation is of any physiological rele-
vance.
4. Mode of action
All biochemical and structural data lead to a mod-
el for the action of OMPLA, which is graphically
summarised in Fig. 4. Normally, OMPLA is present
in the outer membrane as a monomer with a calcium
ion bound at the L3L4 binding site. This form is
inactive owing to the absence of substrate binding
pockets, lack of oxyanion stabilisation and physical
separation of substrate and active site. External or
internal triggers (e.g. bacteriocin release protein in-
duction, temperature shock, polymixin B exposure)
perturb the outer membrane, introducing phospho-
lipids in the outer lea£et. The presence of the phos-
pholipids in the outer lea£et increases the £uidity of
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the outer membrane, which will facilitate lateral dif-
fusion of its embedded components. Besides that,
substrates are presented to the active site of OM-
PLA, which presumably triggers dimerisation. The
calcium ion possibly moves from the L3L4 site to
the active site of OMPLA, thus creating an active
dimer-substrate-cofactor complex.
The active complex hydrolyses the phospholipid
through a mechanism analogous to that of serine
hydrolases. Ser144 performs a nucleophilic attack
on the carbonyl carbon of the ester, facilitated by
polarisation of the ester carbonyl bond by electro-
static interactions with the calcium ion. A negatively
charged tetrahedral intermediate is formed which is
stabilised by the tetrahedral arrangement of hydro-
gen bonds and by the remote in£uence of the calcium
ion. The transient intermediate collapses to give the
enzyme-acyl intermediate. The lysophospholipid can
leave by lateral di¡usion in the membrane. Deacyla-
tion will occur with a water molecule acting as the
nucleophile. The fatty acid product can leave the
active site either by lateral di¡usion into the mem-
brane via the opening between the two monomers or
alternatively by dissociation of the dimer into mono-
mers.
In addition to the membrane perturbing trigger,
release of fatty acids and lysophospholipids destabil-
ises the membrane, possibly resulting in non-bilayer
structures. In vitro the OMPLA activity is strongly
enhanced by non-bilayer structures, resulting in more
rapid generation of fatty acids and lysophospholip-
ids. Hence, the membrane perturbing signal is ampli-
¢ed and the reaction products further permeabilise
the membrane. Thus, semispeci¢c excretion of coli-
cins and other e¡ector molecules is facilitated.
5. Conclusion and perspective
The recently solved structures of OMPLA have
Fig. 4. Model for involvement of OMPLA in bacteriocin release. Under normal conditions OMPLA is in a dormant monomeric form
and the outer lea£et of the membrane consists solely of LPS (A). Under the in£uence of a trigger, for example the bacteriocin release
protein, the membrane bilayer is perturbed and phospholipids are presented in the outer lea£et (B). OMPLA dimers are formed, sub-
strate and calcium are bound in the active site (C). Phospholipids are hydrolysed, lysophospholipids and fatty acids perturb the lipid
bilayer (D). Eventually the outer membrane becomes permeable and bacteriocins can be semispeci¢cally secreted (E).
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yielded a better understanding of membrane protein
interactions, phospholipid metabolism, and function-
ing of this speci¢c phospholipase in particular. It
revealed an entirely new fold of phospholipases and
sheds light on its catalytic properties. However, our
understanding is far from complete. What is the bio-
logical relevance of the L3L4 calcium binding site?
How can the physical state of the lipidic surrounding
modulate enzyme activity? What is the exact biolog-
ical function of OMPLA? How is OMPLA involved
in bacterial pathogenesis? What mechanism arrests
enzymatic activity and averts complete bacterial ly-
sis? In the future, continued biochemical and struc-
tural research are expected to unravel the remaining
secrets and to obtain a full understanding of the
molecular mechanism of this intriguing enzyme.
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